HIGHBRIDGE CAPITAL MANAGEMENT LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2015$950,000
+290.9%
182,572
+619.8%
0.01%
+133.3%
Q3 2014$243,000
-17.1%
25,3640.0%0.00%
-25.0%
Q2 2014$293,000
+15.4%
25,3640.0%0.00%
+33.3%
Q1 2014$254,000
-23.3%
25,364
-0.4%
0.00%
-25.0%
Q4 2013$331,000
-12.4%
25,464
+0.4%
0.00%0.0%
Q3 2013$378,000
+59.5%
25,3640.0%0.00%
+100.0%
Q2 2013$237,00025,3640.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders